Groupe de Recherche sur les formes Injectables et les Technologies Associées

Statistics

Publications

284

Citations

16.1K

Authors

Location

Lille, France

Also known as GRITA

Groupe de Recherche sur les formes Injectables et les Technologies Associées is a facility institution in Lille, France known for medicine, oncology, and immunotherapy.

Homepage ROR

Top concepts

MedicinePharmacologyPharmacyOncologyPharmaceuticsDrug DeliveryChemotherapyPlasticizersNatural SciencesPolymer Chemistry

Publications

284

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

Manali Kamdar, Scott R. Solomon, Jon Arnason et al. · The Lancet · 2022 · 752 citations

Medicine, Oncology, Chemotherapy +13

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser et al. · New England Journal of Medicine · 2022 · 676 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 448 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni et al. · Journal of Clinical Oncology · 2021 · 413 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 284

Authors

AM
Aurélie Maiguy‐Foinard
Groupe de Recherche sur les formes Injectables et les Technologies Associées
8 publications · 103 citations
5
h-index
RG
Romain Gaudy
Groupe de Recherche sur les formes Injectables et les Technologies Associées
3 publications · 81 citations
3
h-index
AD
Anne Deldicque
Groupe de Recherche sur les formes Injectables et les Technologies Associées
3 publications · 29 citations
2
h-index
CC
Claudia Carlucci
Groupe de Recherche sur les formes Injectables et les Technologies Associées
2 publications · 25 citations
2
h-index
ML
Mégann Le Rest
Groupe de Recherche sur les formes Injectables et les Technologies Associées
1 publications · 11 citations
1
h-index

1–5 of 11